EFSA Reaffirms Safety of Aspartame-Acesulfame Salt Amidst Evolving Regulatory Landscape

The European Food Safety Authority (EFSA) has officially concluded its comprehensive re-evaluation of the food additive salt of aspartame-acesulfame (E 962), offering a definitive assessment that should provide clarity for both the food industry and health-conscious consumers. Following a rigorous scientific review process, the Authority’s Panel on Food Additives and Flavorings (FAF) has determined that there are no safety concerns associated with the currently reported uses and use levels of this common sweetener.

This finding serves as a significant milestone in the ongoing monitoring of synthetic sweeteners within the European Union, reaffirming the safety profiles of the individual components—aspartame and acesulfame K—while addressing the specific chemical structure of their combined salt form.

The Science of E 962: Understanding the Additive

Salt of aspartame-acesulfame (E 962) is a specialized sweetener widely authorized for use in a variety of energy-reduced and sugar-free food and beverage products across the EU. Its utility lies in its ability to provide a high-intensity sweetening profile that mimics the sensory experience of sucrose without the associated caloric load.

From a physiological perspective, the additive is categorized as a chemical complex. Upon ingestion, the salt promptly dissociates in the human digestive system, breaking down into its constituent components: aspartame (E 951) and acesulfame K (E 950). Because of this dissociation, EFSA’s safety assessment was inextricably linked to the toxicological profiles of these two individual sweeteners.

The FAF Panel’s investigation involved a thorough examination of current exposure levels across all age groups within the European population. By synthesizing data on typical consumption habits, the Panel determined that estimated exposures remain comfortably below the Acceptable Daily Intake (ADI) thresholds established for both substances.

Chronology of the Re-Evaluation Process

The path to this scientific opinion was marked by years of systematic review, adhering to the highest standards of transparency and evidence-based medicine.

• 2019: EFSA published its finalized protocol for the hazard identification and characterization of sweeteners for public consultation. This document set the methodological foundation for the subsequent assessment.
• 2020: The Authority released its specialized protocol for assessing exposure to sweeteners, again inviting public and stakeholder scrutiny to ensure the model was robust and representative of actual dietary habits.
• July 2026: The FAF Panel formally adopted the scientific opinion during an open plenary meeting, signaling the culmination of the data-gathering and analysis phase.
• Post-2026 Reporting: Following the adoption, the Authority moved to disseminate the findings to regulatory bodies and the public, emphasizing the importance of updated specifications for manufacturing compliance.

This multi-year trajectory reflects the European Union’s "safety-first" approach, where food additives are subjected to periodic re-evaluations to ensure that scientific consensus keeps pace with new toxicological research and shifting consumption patterns.

Supporting Data: Reconfirming ADI Thresholds

The safety conclusion rests upon two critical pillars of toxicological data, both of which were re-examined and upheld by the FAF Panel.

Aspartame (E 951)

The panel reconfirmed the previously established ADI for aspartame at 40 milligrams per kilogram (mg/kg) of body weight per day. Despite historical debates surrounding the safety of aspartame—including high-profile discussions regarding its potential as a carcinogen—the scientific consensus maintained by EFSA remains firm. When consumed within the established ADI, aspartame is considered safe for the general population.

Acesulfame K (E 950)

The evaluation also benefited from a recently revised ADI for acesulfame K, which now stands at 15 mg/kg of body weight per day. This update reflects the most current understanding of the additive’s metabolic behavior and potential long-term impacts.

By cross-referencing these ADIs with current consumption data, the FAF Panel concluded that the European population, including vulnerable subgroups, remains well within the safety margins. The exposure models accounted for high-consumer scenarios, ensuring that the findings are robust even for individuals with higher-than-average intakes of diet beverages and sugar-free confectionery.

Recommended Updates to Specifications

While the safety profile was deemed satisfactory, the FAF Panel issued specific recommendations aimed at enhancing quality control and regulatory oversight.

Compliance and Harmonization

The Panel recommended updating the official EU specifications for E 962. The goal is to ensure that the aspartame and acesulfame K used to synthesize the salt form meet the current, rigorous specifications established for the individual additives. This "chain of quality" approach is designed to prevent the introduction of impurities during the manufacturing of the salt complex.

Monitoring Heavy Metals

In a move consistent with its broader strategy for sweetener regulation, the Panel recommended a review of the maximum limits for arsenic and lead in the specifications for aspartame (E 951). While these elements are often naturally occurring, the Panel’s proactive stance aims to tighten existing limits to ensure that even trace amounts of heavy metals in food additives are kept to the lowest reasonably achievable levels.

Implications for the Food Industry and Regulators

The EFSA report serves as a "green light" for the continued use of E 962, but it also places a burden of responsibility on food manufacturers.

For Industry Stakeholders

Manufacturers currently using salt of aspartame-acesulfame should review their internal quality assurance protocols in light of the recommended updates to EU specifications. Compliance is not merely a matter of safety, but of maintaining consumer trust in an era where ingredient transparency is a top priority for shoppers.

Furthermore, the industry must remain vigilant regarding the labeling of these sweeteners. While the safety of the individual components is affirmed, the move toward cleaner labels and simplified ingredients means that companies must continue to be transparent about the use of E 962 in their product formulations.

For Regulatory Bodies

The EFSA findings will likely inform the European Commission’s next steps regarding the authorization of food additives. By providing a clear scientific basis for the continued use of E 962, the Commission is now better positioned to draft updated regulations that reflect the Panel’s recommendations on heavy metal limits and manufacturing specifications.

The Broader Context: Why Re-Evaluation Matters

The necessity of such exhaustive re-evaluations cannot be overstated. In the modern food environment, synthetic sweeteners are ubiquitous. As consumers increasingly turn to sugar-reduced products to manage metabolic health, obesity, and diabetes, the volume of intake for additives like E 962 has the potential to rise.

EFSA’s commitment to re-evaluating these substances every few years acts as a critical safety net. It allows regulators to incorporate new clinical studies, longitudinal health data, and advanced analytical chemistry techniques that were unavailable when these substances were first approved decades ago.

The public discourse surrounding artificial sweeteners is often fraught with conflicting information, sometimes fueled by social media trends or anecdotal reports. By anchoring the conversation in the methodology of the FAF Panel—which utilizes systematic, peer-reviewed, and publicly consulted data—EFSA helps to mitigate misinformation. The re-evaluation of E 962 is a testament to the fact that when it comes to food safety, the regulatory process is not a "set-it-and-forget-it" system, but a dynamic, iterative, and scientifically rigorous discipline.

Conclusion

The European Food Safety Authority’s conclusion on the salt of aspartame-acesulfame (E 962) provides a clear and reassuring message: the additive remains safe for consumption at current levels. By validating the existing ADIs for its component parts and suggesting prudent updates to manufacturing specifications, EFSA has demonstrated its continued dedication to public health.

As the industry moves forward, the focus will shift toward implementing these updated specifications and ensuring that the high standards of safety identified by the FAF Panel are maintained in every link of the supply chain. For the consumer, the takeaway is clear: the science supports the safety of these ingredients, provided they are consumed within the recommended limits—a standard that the current European diet continues to meet with ease.